Arrowhead Pharmaceuticals
Trade Arrowhead Pharmaceuticals 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About ARWR
Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC.
ARWR Key Statistics
Stock Snapshot
The current Arrowhead Pharmaceuticals(ARWR) stock price is $58.66, with a market capitalization of 8.29B. The stock trades at a price-to-earnings (P/E) ratio of -26.02.
During the trading session on 2026-10-15, Arrowhead Pharmaceuticals(ARWR) shares reached a daily high of $59.40 and a low of $57.70. At a current price of $58.66, the stock is +1.7% higher than the low and still -1.2% under the high.
Trading activity shows a volume of 727.47K, compared to an average daily volume of 2.09M.
The stock's 52-week range extends from a low of $36.02 to a high of $95.49.
The stock's 52-week range extends from a low of $36.02 to a high of $95.49.
ARWR News
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) on Wednesday shared interim data from an ongoing Phase 1/2a clinical trial for ARO-MAPT, an investigational RNA in...
Arrowhead Pharmaceuticals (ARWR) just picked up a fresh regulatory catalyst, with the FDA allowing plozasiran into its STAR pilot program tied to an upcoming sN...
Arrowhead Pharmaceuticals reported that the FDA granted plozasiran, marketed as REDEMPLO, entry into the STAR pilot program for an upcoming sNDA in severe hyper...
Analyst ratings
94%
of 17 ratingsMore ARWR News
Arrowhead Pharmaceuticals, Inc. (ARWR) announced an update on their ongoing clinical study. Arrowhead Pharmaceuticals, Inc. has completed a Phase 3 study calle...
Bond giant Pimco now sees a real chance of US 10 year Treasury yields hitting 6%, which pulls money toward safer income and makes investors choosier about where...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.